• en English
    ar Arabichy Armenianbs Bosnianzh-CN Chinese (Simplified)nl Dutchen Englishtl Filipinofr Frenchde Germaniw Hebrewhu Hungarianit Italianko Koreanfa Persianpt Portuguesepa Punjabiro Romanianru Russianes Spanishta Tamiltr Turkish
(905) 790 2666 Book Appointment Directions
Howden Medical Clinic Howden Medical Clinic
  • Home
  • Services
    • Cosmetics
    • Laboratory Analysis
    • Mental Health
    • Pharmacy
      • Contact Pharmacy
      • Prescription Refill
      • Request Rx Delivery
      • Rx Transfer Request
    • Surgical Procedures
    • Walk-In Clinic
  • Appointments
    • Book An Appointment
  • Pharmacy
  • About
  • Policies
  • Resources
  • Contact
  • News
  • Join Our Team
January 09, 2021January 9, 2021
0

Pharmascience Inc. recalls certain lots of over-the-counter ranitidine

Pharmascience Inc. is recalling 13 additional lots of its store-brand over-the-counter ranitidine products (75 mg strength tablet) after tests found NDMA, a nitrosamine impurity, above accepted levels.

HMC

Share this:

  • Tweet
by Amir KhakshaeeIn Advice,NewsTagged antacidH2 receptor blockermedicinenewsNMDAPharmacypharmasciencePPIranitidinerecallsafety
Previous Link
 Answering Patient Questions about COVID-19 Vaccines 
Next Link
COVID-19 Vaccines

Like this post?

More posts

December 17, 2017December 17, 2017

Diet and Hypertension

May 07, 2018May 7, 2018

Extraordinary!

December 07, 2017December 7, 2017

HelpThemQuit.ca

Like us on Facebook

Facebook
Privacy Policy | Terms of Use | Website by EXNP Inc.
Howden Medical Clinic | All Rights Reserved |